Dr Reddy’s Lab Q2 Finance results announced the Net profit fall 30% YoY to Rs 762 crore

Dr. Reddy’s Lab Q2 Finance results announced the Net profit fall 30% YoY to Rs 762 crore


Wednesday Dr. Reddy Laboratories Limited announced Q2 Finance results report the Net profit falls 30% percent YoY to Rs.762 core as against last year same quarter net profit Rs.1,092 crore.

The company total revenue Q2 YoY growth 2% percent to Rs.4,897 crore September 2020 as against last year the same quarter Rs.4,800.9 crore.

Gross Margin falls 360 bps to 53.9% percent. Earning Before Interest Taxes Depreciation and Amortization (EBITDA) down YoY 12% percent to Rs.1,267 Crore as against last year the same quarter Rs.1,433.7 crore.

Cyber attack update Dr. Reddy

The company official website cyber-attack on 22 October 2020, Dr. Reddy Statement update the news ‘We experienced an information security incident attack the ransomware attack. That day our side investigations have not ascertained if any data breaches in the incident pertaining to personal identification information stored in the company systems.

The company side recovery of all data and applications is underway. All critical operations are being enabled in a controlled manner.


Today market Dr. Reddy Laboratories share price change -2.91% percent down to 148.40 points and in the day market closing price Rs.4,951.


Thank you for reading have more updates Follow Social Media and Stay tune to Businesline.info 

Leave a Comment